非酒精性脂肪性肝病的饮食治疗

doi:10.3969/j.issn.1672-5069.2014.05.002

实用肝脏病杂志 ›› 2014, Vol. 17 ›› Issue (5): 452-455.doi: 10.3969/j.issn.1672-5069.2014.05.002

非酒精性脂肪性肝病的饮食治疗

曹海霞, 范建高

200092 上海市上海交通大学医学院附属新华医院消化内科/上海市儿童消化与营养重点实验室

收稿日期:2014-05-14 出版日期:2014-10-31 发布日期:2016-04-11
通讯作者: 范建高,E-mail:fanjiangao@gmail.com
作者简介:曹海霞,女,33岁,医学博士,主治医师。主要从事慢性肝病防治研究。E-mail:caohaixia204106@126.com

Dietary management of patients with nonalcoholic fatty liver diseases

Cao Haixia, Fan Jiangao

Department of Gastroenterology,Key Laboratory of Children’s Digestion and Nutrition,Xinhua Hospital,Shanghai JiaoTong University School of Medicine,Shanghai 200092,China

Received:2014-05-14 Online:2014-10-31 Published:2016-04-11

摘要/Abstract

关键词: 非酒精性脂肪性肝病, 营养, 饮食, 减重, 治疗

Key words: Nonalcoholic fatty liver diseases, Nutrition, Diet, Weight loss, Treatment

曹海霞, 范建高. 非酒精性脂肪性肝病的饮食治疗[J]. 实用肝脏病杂志, 2014, 17(5): 452-455.

Cao Haixia, Fan Jiangao. Dietary management of patients with nonalcoholic fatty liver diseases[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(5): 452-455.

[1] Fan JG. Epidemiology of alcohol and nonalcoholic fatty liver disease in China. J Gastroenterol Hepatol,2013,28（Suppl 1）:11-17.
[2] Yilmaz Y,Younossi ZM. Obesity-associated nonalcoholic fatty liver disease. Clin Liver Dis,2014,18:19-31.
[3] 陈东风, 熊吉. 非酒精性脂肪性肝炎:现状与未来. 实用肝脏病杂志,2013,16（6）:481-482.
[4] Angulo P. Nonalcoholic fatty liver disease. N Engl J Med, 2002,346:1221-1231.
[5] Machado M,Marques-Vidal P,Cortez-Pinto H. Hepatic histology in obese patientsundergoing bariatric surgery. J Hepatol,2006,45:600-606.
[6] Cao HX,Fan JG. Editorial:Fatty liver disease:a growing public health problem worldwide. J Dig Dis,2011,12:1-2.
[7] 沈峰,丁晓东,范建高. 美国非酒精性脂肪性肝病诊疗指南简介. 实用肝脏病杂志,2012,15（4）:362-363.
[8] Asrih M,Jornayvaz FR. Diets and nonalcoholic fatty liver disease:The good and the bad. Clin Nutr,2013 Nov 8. pii: S0261-5614（13）00304-X. doi:10.1016/j.clnu.2013.11.003. [Epub ahead of print]
[9] Mouzaki M,Allard JP.The role of nutrients in the development, progression,andtreatment of nonalcoholic fatty liver disease. J Clin Gastroenterol,2012,46:457-467.
[10] McCarthy EM,Rinella ME. The role of diet and nutrient composition in nonalcoholic fatty liver disease. J Acad Nutr Diet,2012,112:401-409.
[11] de Wit NJ,Afman LA,Mensink M,et al. Phenotyping the effect of diet onnon-alcoholic fatty liver disease. J Hepatol,2012,57:1370-1373.
[12] Sacks FM,Bray GA,Carey VJ,et al. Comparison of weight-loss diets with different compositions of fat,protein,and carbohydrates. N Engl J Med,2009,360:859-873.
[13] Yasutake K,Kohjima M,Nakashima M,et al. Nutrition therapy for liver diseases based on the status of nutritional intake. Gastroenterol Res Pract,2012,2012:859697.
[14] 范建高,曾民德. 脂肪性肝病. 2版.北京：人民卫生出版社, 2013:459-467.
[15] Moyer VA.U.S. Preventive Services Task Force. Screening for and managementof obesity in adults:U.S. Preventive Services Task Force recommendation statement. Ann Intern Med,2012,157:373-378.
[16] 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南. 中华肝脏病杂志,2010,18:153-166.
[17] Thoma C,Day CP,Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults:a systematic review. J Hepatol,2012,56:255-266.
[18] Musso G,Cassader M,Rosina F,et al. Impact of current treatments on liver disease,glucose metabolism and cardiovascular risk in non-alcoholic fattyliver disease（NAFLD）:a systematic review and meta-analysis of randomizedtrials. Diabetologia,2012,55:885-904.
[19] Nomura K,Yamanouchi T. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. J Nutr Biochem,2012,23:203-208.
[20] Colak Y,Tuncer I,Senates E,et al. Nonalcoholic fatty liver disease:anutritional approach. Metab Syndr Relat Disord,2012,10:161-166.
[21] Jun DW. The role of diet in non-alcoholic fatty liver disease. Korean J Gastroenterol,2013,61:243-251.
[22] Utzschneider KM,Bayer-Carter JL,Arbuckle MD,et al. Beneficial effect of weight-stable,low-fat/low-saturated fat/low-glycaemicindex diet to reduce liver fat in older subjects. Br J Nutr,2013,109:1096-1104.
[23] Parker HM,Johnson NA,Burdon CA,et al. Omega-3 supplementation and non-alcoholic fatty liver disease:a systematic review and meta-analysis. J Hepatol,2012,56:944-951.
[24] Bortolotti M,Kreis R,Debard C,et al. High protein intake reduces intrahepatocellular lipid deposition in humans. Am J Clin Nutr,2009,90:1002-1010.
[25] Tovar AR,Torres N. The role of dietary protein on lipotoxicity.Biochim Biophys Acta,2010,1801:367-371.
[26] Corbin KD,Zeisel SH. Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Curr Opin Gastroenterol,2012,28:159-165.
[27] Masterjohn C,Bruno RS. Therapeutic potential of green tea in nonalcoholic fatty liver disease. Nutr Rev,2012,70:41-56.
[28] Birerdinc A,Stepanova M,Pawloski L,et al. Caffeine is protective in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther,2012,35:76-82.
[29] Dunn W,Sanyal AJ,Brunt EM,et al. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease （NAFLD）. J Hepatol,2012,57:384-391.
[30] Pacana T,Sanyal AJ. Vitamin E and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care,2012,15:641-648.
[31] Eslamparast T,Poustchi H,Zamani F,et al. Synbiotic supplementation in nonalcoholic fatty liver disease:a randomized, double-blind,placebo-controlled pilot study. Am J Clin Nutr,2014 Jan 8 [Epub ahead of print].
[32] 曹毅, 范建高. 肠道微生态制剂对非酒精性脂肪性肝病的防治作用. 中华医学杂志,2013,93:3235-3237.
[33] 赵欢, 赵彩彦. 肠道菌群失调在慢性肝病发病中的作用研究进展. 实用肝脏病杂志,2014,17（1）:106-108.
[34] Assy N. Nutritional recommendations for patients with non-alcoholicfatty liver diseases. World J Gastroenterol,2011,17:3375-3376.
[35] 茅益民, 曾民德. 加强非酒精性脂肪性肝病的临床和转化医学研究. 实用肝脏病杂志,2012,15（4）:273-275.

非酒精性脂肪性肝病的饮食治疗

Dietary management of patients with nonalcoholic fatty liver diseases

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	鲍应军, 任伟新. 门静脉血栓介入治疗研究进展[J]. 实用肝脏病杂志, 2019, 22(6): 768-769.
[2]	中国研究型医院学会肝病专业委员会, 中国医师协会脂肪性肝病专家委员会. 脂肪性肝病诊疗规范化的专家建议（2019年修订版）[J]. 实用肝脏病杂志, 2019, 22(6): 787-792.
[3]	. 肝纤维化诊断及治疗共识（2019年）[J]. 实用肝脏病杂志, 2019, 22(6): 793-803.
[4]	任俞霏, 陈小青, 孔维宗, 王迎春. 丹酚酸B对非酒精性脂肪性肝病细胞模型自噬功能的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 804-807.
[5]	石莹莹, 王元喜. 替比夫定联合阿德福韦酯治疗慢性乙型肝炎患者效果及其对肾功能的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 820-823.
[6]	李颖怡, 郭翠芬, 章瑞南, 汪保灿, 潘勤, 汪余勤, 曹海霞, 范建高. ALDH2 rs671基因多态性与非酒精性脂肪性肝病相关性研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 848-851.
[7]	邢欣, 魏重操, 周咪咪, 李小玲, 邓江, 鲁晓岚. 牛磺熊去氧胆酸与熊去氧胆酸治疗非酒精性脂肪性肝病患者疗效和安全性的Meta分析[J]. 实用肝脏病杂志, 2019, 22(6): 852-855.
[8]	段楚瑶, 陈庆山, 汪黎明, 贺晓琪. 熊去氧胆酸治疗妊娠期肝内胆汁淤积症患者疗效研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 864-867.
[9]	陈梅梅, 段晓燕, 曹海霞, 丁雯瑾. 复方鳖甲软肝片治疗原发性胆汁性肝硬化患者疗效分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 880-883.
[10]	马雅琼, 李芝兰, 夏冰. 早期肠内营养联合微生态制剂治疗肝性脑病患者肠道菌群的改变^*[J]. 实用肝脏病杂志, 2019, 22(6): 892-895.
[11]	冯文广, 姜伟, 宋国军. PPV指导术中液体治疗对行肝部分切除术治疗的肝内胆管结石患者术后并发症发生的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 912-915.
[12]	黎秋曦, 贾健锋, 黄锐. 区段肝蒂肝切除术与B超引导下肝切除术治疗肝胆管结石患者临床价值分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 916-919.
[13]	李传杰, 徐静, 王亮亮, 潘劲劲, 刘波. 恩替卡韦治疗慢性乙型肝炎患者血清HBsAg变化与病毒学应答的相关性研究[J]. 实用肝脏病杂志, 2019, 22(6): 928-929.
[14]	张瑞, 王剑, 陈世耀. 肝硬化门脉高压症并发血栓形成机制和治疗研究进展^*[J]. 实用肝脏病杂志, 2019, 22(6): 930-933.
[15]	梁巨波, 苗琪, 马雄. 胆管细胞型胆汁淤积诊治进展[J]. 实用肝脏病杂志, 2019, 22(6): 941-943.